2026 PROGRAM &
PROGRAM AT A GLANCE

Color Coding Key

  • Dark navy — keynote/invited symposia

  • Gold — plenary/award sessions

  • Teal — poster sessions

  • Green — Concurrent Session A

  • Orange — Concurrent Session B

  • Purple — Social events

  • Grey — breaks/registration

ANZBMS 2026 Program
ANZBMS 2026

Program

This program is preliminary and subject to change.
Opens your browser's print dialog — choose "Save as PDF" as the destination.
Session Types General Session Keynote / Symposium Concurrent Session A Concurrent Session B Plenary / Award Session Poster Session Social / Evening Event Break / Registration
Talk Types Invited Speaker Oral Abstract Clinical Case
Registration Open
1:30 PM – 7:30 PM L5 Foyer 1 & 2
ANZBMS Council Meeting
2:30 PM – 4:00 PM Room 401
ANZBMS President's Function (by invitation only)
4:00 PM – 5:00 PM Room 401
Welcome to Country & Welcome Remarks
4:30 PM – 5:00 PM Meeting Room 503/504/505
The Great Debate
5:00 PM – 6:00 PM Meeting Room 503/504/505
ANZBMS Plenary Posters Session
6:00 PM – 6:30 PM L5 Foyer 1 & 2
Fracture Site, Aging, and Multimorbidity Shape Post-Fracture Consequences: A Whole-of-Population Study
Thach Tran
Arginase-2 drives osteoarthritis progression by coupling arginine dysregulation to mitochondrial dysfunction in chondrocytes
Luxi Zheng
Determinants and Trends of Bone Mineral Density in Transfusion-Dependent Thalassaemia: A Retrospective Single-Centre Cohort Analysis
Evan EZ Zhang
Bone marrow adipocytes fuel myeloma: phenotype and lipid profiling in MGUS and multiple myeloma
Melissa D Cantley
Mapping the osteoclast methylome and investigating its role in osteoporosis
Benjamin H Mullin
Spermidine improves fast-twitch muscle histopathology and specific-force, with no impact on bone, in the mdx mouse model of Duchenne muscular dystrophy
Ahmed Al Saedi
Cortical and trabecular bone changes in men with haemophilia: findings from The Haemophilia Osteoporosis Registry (THOR)
Ayse Zengin
The association between low bone mineral density and osteoporosis with machine-learning abdominal aortic calcification in the UK Biobank Imaging study
Cassandra Smith
Audit of a tertiary hospital fracture liaison service as part of the national fragility fracture network strengths and weakness
Virginia T Katsidzira
Development of a cyclic peptide for SOST targeting to prevent osteoporosis
Gongli Cai
Welcome Function
6:30 PM – 7:30 PM L5 Foyer 1 & 2
Bones & Bites
7:30 PM – 10:00 PM
Registration Open
7:30 AM – 8:00 PM L5 Foyer 1 & 2
Symposium: The New Anabolic Era: Optimising Sequencing, Cycling and Exit Strategies
8:30 AM – 9:15 AM Meeting Room 503/504/505
The New Anabolic Era: Optimising Sequencing, Cycling, and Exit Strategies
Bente Langdahl
Invited Speaker
ANZBMS Outstanding Abstracts
9:15 AM – 10:15 AM Meeting Room 503/504/505
Targeted GP alerts improve osteoporosis treatment after minimal trauma fracture: Outcomes of the INTERCEPT multicentre cluster randomised controlled trial
Mawson Wang
Oral Abstract
High-dose estradiol restores vertebral micro-architecture and strength in an adolescent mouse model of male-to-female transition
Varun S Venkatesh
Oral Abstract
Increased STAT3 or VEGF signalling in the osteoblast lineage leads to greater cortical porosity in the adult skeleton
Natalie YY Koh
Oral Abstract
Morning Tea
10:15 AM – 10:45 AM L5 Foyer 1 & 2
Roger Melick Young Investigator Award Symposium
10:45 AM – 12:45 PM Meeting Room 503/504/505
Patterns of osteoporosis treatment initiation following low-trauma fracture: an Australian population-based cohort study
Mike Lin
Oral Abstract
Repurposing FDA-Approved Drugs Targeting OXR1 to Suppress Osteoclastogenesis and Prevent Bone Loss
Xiaojun X.C. Chen
Oral Abstract
Paternal occupational and household exposures during pregnancy; is there an association with offspring adult bone health and body composition?
Mia Percival
Oral Abstract
Preterm piglets as a translational large-animal model of osteopenia of prematurity
Kun-Di Lee
Oral Abstract
Hypophosphataemia following parenteral iron and antiresorptives in clinical practice
Karen Van
Oral Abstract
Using single-cell transcriptomics to identify gene regulatory networks involved in rare skeletal disorders
Nilabhra R. Das
Oral Abstract
Rethinking long-term denosumab therapy: extending treatment intervals in low-risk patients
Brenda Ta
Oral Abstract
Central dopaminergic lesion induces asymmetrical femoral deterioration that becomes bilateral with limited oestrogen production
Tahnee B C Thatcher
Oral Abstract
Lunch
12:45 PM – 2:00 PM L5 Foyer 1 & 2
Kyowa Kirin Sponsored Lunchtime Symposium
1:00 PM – 2:00 PM Room 507 & 508
Concurrent Session A
Symposium: Bone Health 2026 — Clinical Updates
2:00 PM – 3:30 PM Meeting Room 503/504/505
Bone Health 2026: Clinical Updates
Hanh Nguyen
Invited Speaker
The BMD response to ONERO exercise is driven by load magnitude and the BMD response to bone medication is enhanced by ONERO
Belinda R Beck
Oral Abstract
Chronic multisite pain is associated with an increased risk of incident fracture at all major sites: a prospective cohort study
Nikola Markovic
Oral Abstract
Associations of osteoporosis and fracture with incident cardiovascular disease: A systematic review and meta-analysis
Joshua R Lewis
Oral Abstract
Cortical and trabecular microarchitectural deterioration in women with prosthetic hip and knee joint replacement
Ali Ghasem-Zadeh
Oral Abstract
Reimagining routine health information systems to detect fracture risk and osteoporosis: a policy brief for the World Health Organisation (WHO)
Marc Sim
Oral Abstract
Concurrent Session B
Symposium: Beyond Mechanics — Endocrine and Cellular Crosstalk Between Muscle and Bone
2:00 PM – 3:30 PM Room 507 & 508
Beyond Mechanics: Endocrine and Cellular Cross Talk Between Muscle and Bone
Itamar Levinger
Invited Speaker
Plasma Membrane-Endoplasmic Reticulum Tethering Drives Mechanotransduction in Bone and Tendon Cells
Ziming Chen
Oral Abstract
Older women deposit bone with less collagen cross-linking and glycosaminoglycan content than bone made by younger women
Mary Louise Fac
Oral Abstract
Mfsd12 deficiency in mice causes bone loss and a multisystem lysosomal storage disorder
Jasreen Kular
Oral Abstract
Anti-tuberculosis drug bedaquiline suppresses osteoclastogenesis and prevents bone loss by modulating glycolysis and histone lactylation
Lizhen Li
Oral Abstract
Study on Gut Microbiota-Induced Ferroptosis in Bone Marrow of Ovariectomized Mice
Lei Chen
Oral Abstract
Afternoon Tea
3:30 PM – 4:00 PM L5 Foyer 1 & 2
Symposium: Cutting Edge Tools to Study Bone
4:00 PM – 5:15 PM Meeting Room 503/504/505
Cutting edge tools to study bone
Edwin Hawkins
Invited Speaker
Genetic determinants of trabecular bone score and their relationships with bone mineral density and fragility fractures
John P Kemp
Oral Abstract
Longitudinal change in 3D shaper analysis versus aDXA in patients receiving romosozumab
Angela Sheu
Oral Abstract
A novel surgical membrane with integrated antimicrobial nanoparticles for bone regeneration
Dawn E Coates
Oral Abstract
Clinical Cases in Metabolic Bone Disease Seminar & Dinner
6:30 PM – 10:00 PM Meeting Room 503/504/505
Successful treatment of symptomatic hypercalcaemia in FHH Type 3 with cinacalcet
Jack AL Cooper
Clinical Case
A Skeleton in the Genome: Digenic Inheritance Unmasking a Progeroid Bone Fragility Syndrome
Sarah C Brennan
Clinical Case
A Cautionary Tale: The Unknowns of Denosumab in Active High-Turnover McCune-Albright Syndrome
Christopher Chan
Clinical Case
A diagnostic dilemma: a case report of PTH-independent hypercalcaemia in pregnancy
Dhiraj Samarasinghe
Clinical Case
Registration Open
7:00 AM – 8:00 PM L5 Foyer 1 & 2
ECIC Breakfast Symposium
7:15 AM – 8:30 AM Room 507 & 508
Symposium: Interactions Between the Gut Microbiome and Bone
8:30 AM – 9:15 AM Meeting Room 503/504/505
Interactions Between the Gut Microbiome and Bone
Christopher Hernandez
Invited Speaker
Christopher and Magie Nordin Young Investigator Award
9:15 AM – 10:15 AM Meeting Room 503/504/505
Accelerating Large-Area Ultrastructural Imaging of Bone Tissues by Integrating SEM-BSE with Diffusion-Based Deep Learning
Qiongxiang Q.L. Lin
Oral Abstract
Bisphosphonates, vitamin D and calcium supplements in association with blood pressure in men
Rishitha Panuganti
Oral Abstract
Lactoferrin enhances flucloxacillin activity against Staphylococcus aureus biofilms in periprosthetic joint infections
Yang Sun
Oral Abstract
Differential sensitivity to Wnt-3a and Wnt-5a signaling in primary osteoblasts isolated from hip and knee joints
Leilei Xu
Oral Abstract
Burosumab-associated musculoskeletal improvement in a PHEX-negative adult with X-linked hypophosphataemia after prolonged conventional therapy
Tomasz J Block
Oral Abstract
Correction of genetic dwarfism (achondroplasia) using CRISPR base-editing
Julian Chu
Oral Abstract
Investigating the link between osteocyte health and paraspeckle formation in mechanical stress
Dane Webster
Oral Abstract
Quantification of bone loss, periosteal bone formation and histopathological changes to the bone matrix in a mouse implant-related infection model
Qi Sun
Oral Abstract
Effects of Bisphosphonates on Bone Structural Mechanical Properties in Ovariectomized Non-Human Primates: A Systematic Review and Meta-Analysis
Anna Maria Markarian
Oral Abstract
Morning Tea
10:15 AM – 10:45 AM L5 Foyer 1 & 2
Christopher and Magie Norton Poster Viewing
10:15 AM – 10:45 AM
ANZBMS ECIC BONE Symposium 1
10:45 AM – 11:15 AM Meeting Room 503/504/505
ANZBMS ECIC BONE Symposium 2
11:15 AM – 11:45 AM Meeting Room 503/504/505
Osteogrow-D: A Personalized Regenerative Strategy for Diverse Skeletal Environments
Nikola Stokovic
Invited Speaker
Poster Session 1
11:45 AM – 12:45 PM L5 Foyer 1 & 2
Bone quality deteriorates in elastase-induced emphysema mice
Manabu Tsukamoto
Trabecular bone loss caused by circadian rhythm disruption is partially reversible in mice
Eugenie Macfarlane
Effects of denosumab or romosozumab on vascular calcification in dialysis patients — a systematic review and meta-analysis
Dueanchonnee Sribenjalak
Clinical Observation on Pain Relief and Functional Recovery of Ankle Fracture Patients Based on Traditional Chinese Medicine Fumigation Therapy
Yan Fu
Bone Mineral Density Response to Romosozumab in Severe Osteoporosis Associated with Spinal Cord Injury
Sarah C Brennan
Failure of Antiresorptive Therapy in Severe Osteoporosis: Implications for Perioperative Bone Optimisation
Thomas Ulahannan
Serum bicarbonate concentration is associated with lower bone mineral density at the lumbar spine in men
Kara Anderson
Musculoskeletal decline, intrinsic capacity and all-cause mortality for men in the Geelong Osteoporosis Study
Julie A Pasco
Bilateral spontaneous atypical femoral fractures: a highly morbid presentation of adult hypophosphatasia after delayed diagnosis
Erin Paul
When bone meets blindness: a case of osteoporosis-pseudoglioma syndrome complicated by atypical femur fracture
Jennifer Ngan
Breaking Convention: A Case Report of a Possible Atypical Ulna Fracture
Alec Ronan
Lunch
12:45 PM – 2:00 PM L5 Foyer 1 & 2
Theramex Bone Building Lunchtime Symposium: Meet the NEW anabolic - Eladynos: from science to patient selection
1:00 PM – 2:00 PM Room 507 & 508
Concurrent Session A
Symposium: From Weight Loss to Bone Loss? Understanding Bone Health in the Obesity Drug Era
2:00 PM – 3:30 PM Meeting Room 503/504/505
From Weight Loss to Bone Loss? Understanding Bone Health in the Obesity Drug Era
Angela Sheu
Invited Speaker
Powerful engine, fragile chassis: lower bone mineral density in elite male cyclists despite high aerobic fitness
Ayse Zengin
Oral Abstract
Body composition indices, physical function, and risk of fall and fracture in middle-aged adults: the Busselton Healthy Ageing Study
Kun Zhu
Oral Abstract
Improved Body Composition, Gait Speed, and Personal Care in Older Adults in Aged Care: The Pomerium Study Trial
Ahmed Al Saedi
Oral Abstract
Associations between modifiable lifestyle factors and incident fracture over ten years of follow-up
Kara B Anderson
Oral Abstract
Higher skeletal muscle mass predicts reduced minimal trauma fracture and greater bone mineral density in Australian post-menopausal women
David M Medveczky
Oral Abstract
Concurrent Session B
Symposium: Senescence, Rejuvenation, and Bone Ageing
2:00 PM – 3:30 PM Room 507 & 508
A decade of discovery: epigenetic control of mesenchymal stem cell fate links bone ageing, osteoporosis, and metabolic disease
Dimitrios D.C Cakouros
Invited Speaker
ACC1-mediated mitochondrial fatty acid synthesis (mtFAS) governs osteoclast activation and bone loss
Zhongxiang Wang
Oral Abstract
EphrinB2:EphB4 signalling limits lysosome formation in osteoblasts; in its absence lysosomes and collagen promote mineralisation
Martha Blank
Oral Abstract
Endogenous glucocorticoids induce neurogenic heterotopic ossification via mesenchymal and myeloid cells
Kylie A Alexander
Oral Abstract
SOST-targeted Antisense Oligonucleotide Mimics Splicing Mutation in Sclerosteosis to Enhance Osteogenesis In Vitro
Jun Yuan
Oral Abstract
Hyperbranched Polyglycerol-Coated Titanium Implants Reduce In Vivo Bacterial Burden Without Compromising Osseointegration
Paul H Anderson
Oral Abstract
Poster Session 2
3:30 PM – 4:30 PM L5 Foyer 1 & 2
A Patient-Derived DYSF Microdeletion Model Reveals Muscular Degeneration and Implications for Muscle-Bone Health
Ying-Hung Lin
Targeting EFEMP1 Enhances Chondrogenesis and Inhibits Hypertrophic Differentiation in a Spontaneous Osteoarthritis Mouse Model
Mei-Feng Chen
Role of Membrane-Bound Phosphatase in the Balance Between Osteoclastogenesis and Adipogenesis Under Local Phosphorus Environment
Keito Matsubayashi
The association between emotional and behavioural problems and bone health: Is there a link in childhood?
Natalie Hyde
Elevated fracture risk in women with bipolar disorder
Kara B Anderson
REMS derived bone mineral density (BMD) variability observed across age and BMI segments from a large Australian patient cohort
Sherif Youssef
A Familial Cluster of Atypical Femoral Fractures Suggesting a Heritable Syndrome
Anushka Sharma
When Bone Breaks Under Pressure: Severe Osteoporosis and Hypercalcaemia in Prolonged Critical Illness
Yi Shan Der
When survival outpaces evidence: bone health management in adults with Duchenne muscular dystrophy
Brenda Ta
Atypical parathyroid adenoma presenting with severe PTH-dependent hypercalcaemia
Aishah Virk
Afternoon Tea
3:30 PM – 4:00 PM L5 Foyer 1 & 2
ANZBMS Annual General Meeting
6:00 PM – 7:00 PM Meeting Room 503/504/505
ANZBMS Conference Dinner
7:00 PM – 11:00 PM Meeting Room 503/504/505
Registration Open
8:00 AM – 1:30 PM L5 Foyer 1 & 2
Symposium: Research Co-Design and Consumer Engagement
8:30 AM – 10:00 AM Meeting Room 503/504/505
Morning Tea
10:00 AM – 10:30 AM L5 Foyer 1 & 2
Past Awardees Session
10:30 AM – 11:30 AM Meeting Room 503/504/505
Symposium: Skeletal Fragility After Cancer Therapy
11:30 AM – 12:00 PM Meeting Room 503/504/505
Skeletal Fragility After Cancer Therapy
Frances Milat
Invited Speaker
Symposium: From Pixels to Patients — Digital Innovations in Bone Health
12:00 PM – 1:00 PM Meeting Room 503/504/505
From Pixels to Patients: Digital Innovations in Bone Health
Marion Mundt
Invited Speaker
A Novel Deep Learning Application to Predict High-risk Fracture Patients for Imminent Non-Fracture Re-Hospitalisations
Thach Tran
Oral Abstract
Clinically Interpretable Predictors of Imminent Subsequent Fractures in a Deep-Learning Prediction Model
Huy Nguyen
Oral Abstract
Conference Closing & President's Farewell Message
1:00 PM – 1:15 PM Meeting Room 503/504/505
This program is preliminary and subject to change. All times are NZST.